Text Size
1848 studies found for:    Ovarian Cancer: Clinical Trials

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Active, not recruiting Clinical Trial Investigating Pazopanib in Patients With Platinum-resistant Advanced Ovarian Cancer
Condition: Platinum-resistant Advanced Ovarian Cancer
Intervention: Drug: Pazopanib
2 Unknown † Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Other: screening questionnaire administration;   Procedure: study of high risk factors
3 Recruiting A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor
Conditions: Metastatic Solid Tumor;   Breast Cancer;   Ovarian Cancer
Intervention: Drug: Rucaparib
4 Completed
Has Results 		Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma
Conditions: Ovarian Carcinoma;   Peritoneal Neoplasms
Intervention: Drug: Docetaxel and Gemcitabine
5 Completed Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172
Condition: Ovarian Cancer
Intervention: Procedure: quality-of-life assessment
6 Completed
Has Results 		Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Primary Peritoneal Neoplasms
Intervention: Drug: Pegylated L-Asparaginase
7 Active, not recruiting A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Conditions: Cancer;   Carcinoma;   Fallopian Tube Cancer;   Gynecological Malignancies;   Metastases;   Oncology;   Ovarian Cancer;   Solid Tumors;   Tumors
Interventions: Drug: A1: AMG 386 10 mg/kg + Liposomal doxorubicin;   Drug: A3: AMG 386 15mg/kg + Liposomal doxorubicin;   Drug: B1: AMG 386 10 mg/kg + Topotecan;   Drug: B3: AMG 386 15mg/kg + Topotecan
8 Completed Assess Cancer in Ovarian Tumors With Biomarkers.
Condition: Ovarian Tumor
Intervention: Procedure: Blood Draw
9 Completed Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer
Condition: Epithelial Ovarian Cancer
Intervention: Drug: Voreloxin Injection
10 Active, not recruiting Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)
Conditions: Ovarian Epithelial Cancer;   Ovarian Germ Cell Tumor
Interventions: Other: cytology specimen collection procedure;   Procedure: ultrasound imaging;   Other: screening questionnaire administration
11 Terminated Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse
Condition: Ovarian Cancer
Intervention: Drug: Temsirolimus
12 Recruiting A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: Carboplatin & paclitaxel;   Biological: Carboplatin & paclitaxel & oregovomab
13 Completed Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients
Conditions: Ovarian Cancer;   Healthy Volunteers
Intervention: Drug: Tc 99m EC20
14 Active, not recruiting A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: ABT-888;   Drug: pegylated liposomal doxorubicin;   Drug: temozolomide
15 Unknown † Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor
Conditions: Platinum Refractory Epithelial Ovarian Cancer;   Primary Cancer of the Peritoneum;   Cancer of the Fallopian Tube
Interventions: Drug: Sunitinib;   Drug: SUNITINIB
16 Unknown † Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial
Condition: Ovarian Neoplasms
Intervention: Procedure: neoadjuvant chemotherapy (Carboplatin/Docetaxel)
17 Recruiting Phase Ib Trial of Folate Binding Protein Vaccine in Ovarian Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer
Interventions: Biological: E39 peptide vaccine;   Other: Clinical tracking for disease progression/recurrence
18 Recruiting BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian Cancer
Condition: Ovarian Cancer, Peritoneal Neoplasms
Intervention:
19 Active, not recruiting Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
Conditions: Breast Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Other: questionnaire administration;   Procedure: evaluation of cancer risk factors;   Procedure: quality-of-life assessment;   Procedure: study of high risk factors
20 Active, not recruiting Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: decitabine
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years